Quantum BioPharma Announces $750 Private Placement to Advance Multiple Sclerosis Treatment Development

Quantum BioPharma Ltd. has announced a non-brokered private placement of up to 30 Class A multiple voting shares at $25 per share, aiming to raise gross proceeds of up to $750. The offering, approved by shareholders on September 26, 2025, is expected to be fully subscribed by entities controlled by Zeeshan Saeed and Anthony Durkacz. This strategic move will result in voting rights attached to the Class A shares increasing to 75.27%, effectively restoring them to nearly their original level when the company went public in 2018.

The biopharmaceutical company plans to use the proceeds for general working capital purposes as it advances its portfolio of innovative assets and biotech solutions. This funding comes at a critical time for the company, which focuses on developing treatments for neurodegenerative, metabolic, and alcohol misuse disorders. The company's research and development efforts are primarily channeled through its wholly owned subsidiary, Lucid Psycheceuticals Inc., which is focused on developing the lead compound Lucid-MS.

Lucid-MS represents a significant advancement in multiple sclerosis treatment, being a patented new chemical entity that has demonstrated the ability to prevent and reverse myelin degradation in preclinical models. Myelin degradation is recognized as the underlying mechanism of multiple sclerosis, making this development particularly important for patients suffering from this debilitating condition. The company maintains additional revenue streams through its ownership stake in Unbuzzd Wellness Inc., where it retains 20.11% ownership as of March 31, 2025, along with royalty payments of 7% of sales from the unbuzzd(TM) product until payments total $250 million, after which the royalty drops to 3% in perpetuity.

Quantum BioPharma's strategic positioning extends beyond pharmaceutical development, as the company maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property. Investors can access the latest news and updates relating to QNTM in the company's newsroom at https://ibn.fm/QNTM. The private placement announcement was distributed through InvestorWire, a specialized communications platform that provides advanced wire-grade press release syndication as part of the Dynamic Brand Portfolio at IBN, which can be accessed at https://www.InvestorWire.com.